In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
ESC Congress 2019 Scientific Programme & Planner

Start customise the programme to your needs.

Browse now

Meet the Legends and Experts

ESC Congress 2019 together with World Congress of Cardiology




 

ESC Named Lectures

C R Bezzina (Amsterdam, NL)

Sunday 1 September 15:30 - ESC William Harvey Lecture on Basic Science

When genetic burden reaches threshold


Connie Bezzina Photo.pngConnie Bezzina graduated in Pharmacy from the University of Malta in 1992 and obtained her PhD in Genetics from the same university in 1998. Thereafter, she joined the Department of Experimental Cardiology at the Amsterdam University Medical Center and was appointed Professor of Molecular Cardiogenetics in 2012. She conducts research on genetic factors underlying inherited cardiac disorders, focusing mainly on primary electrical disorders associated with sudden cardiac death. Her work considers the broad spectrum of genetic complexities of these disorders, ranging from monogenic to polygenic, and has pioneered the concept of polygenic inheritance in the rare rhythm disorders such as Brugada syndrome. To enable such studies, she established international consortia of researchers from all over the world, bringing together hundreds of patients. In an integrative approach her group also studies the identified genetic factors in induced pluripotent stem cell derived cardiomyocytes and gene-targeted mice in order to understand the causative mechanisms and identify preventive and therapeutic strategies. She has authored over 170 publications. In 2017 she was appointed a member of the Royal Netherlands Academy of Arts and Sciences.

S James (Uppsala, SE)

Saturday 31 August 10:10 - ESC Paul Hugenholtz lecture for innovation

Creating a learning health care system of evidence generation by linking clinical registries, trials and biobanks

Stefan James Photo2.jpg

Stefan James is Professor of Cardiology at Uppsala University, Scientific Director of Uppsala Clinical Research Center and a senior Interventional Cardiologist at Uppsala University Hospital Sweden. He is the president of the Swedish society of Cardiology and a Fellow of the European Society of Cardiology. Professor James co-chaired the previous and current 2017 ESC guidelines for ST-elevation myocardial infarction, co-author of several of the recent European guidelines on ACS and revascularization.

Stefan James has served on executive steering committees for numerous international trials in cardiology. He has long served as the chairman of the Swedish Coronary and Angioplasty registry and a member of the steering committee of SWEDEHEART.  He has pioneered the concept of registry based randomized clinical trials. His research has been published in 400 peer-reviewed cardiology journals, and he is an associate editor of Circulation and an editorial board member for the European Heart Journal. Last year, he was named by Thomson Reuters as a ‘Highly Cited Researcher’, ranking him among the top 1% most cited in clinical medicine.

 

R Mehran (New York, USA)

Monday 2 September 15:50 - ESC Andreas Grüntzig Lecture on Interventional Cardiology

The evolution of dual antiplatelets therapies/antithrombotic regimens in interventional cardiology: a thirty year journey

Roxana Mehran Photo.jpg

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI; Professor of Medicine at the Icahn School of Medicine at Mount Sinai is an internationally renowned clinical research expert in the field of interventional cardiology. As Director of the Center for Interventional Cardiovascular Research and Clinical Trials at Mount Sinai, she has built a globally-respected academic research center focused on developing randomized clinical trials, outcomes research projects and high impact academic publications. A prolific researcher, she has served as principal investigator for numerous global studies, developed risk scores for bleeding and acute kidney injury, participates regularly in developing clinical guidelines, and has authored >900 peer-reviewed articles. She is a founder and Chief Scientific Officer of the Cardiovascular Research Foundation (CRF) and recently founded Women as One, an independent nonprofit organization dedicated to advancing opportunities for women in medicine. Very active within professional organizations, Dr. Mehran has been the Chair of the Interventional Council for the American College of Cardiology (ACC); Program Chair of the 2016 Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI), where she is also a co-founder of the Women in Innovations (WIN) Committee; and is a member of the American Heart Association's (AHA) Go Red for Women Scientific Advisory Group. Prior to Mount Sinai, Dr. Mehran held appointments at Columbia University Medical Center and Washington Hospital Center. She completed fellowships in cardiovascular disease and interventional cardiology at Mount Sinai Medical Center. Dr. Mehran is a recipient of the 2019 Ellis Island Medal of Honor.

 

K Sliwa-Hahnle (Cape Town, ZA)

Sunday 1 September 10:20 - ESC Geoffrey Rose Lecture on Population Sciences

Heart Failure - Can affect everyone

Karen Sliwa photo.jpg

Karen Sliwa is widely recognised as a world expert in cardiovascular diseases (CVDs), with a particular interest in reducing mortality in women with cardiovascular disease (CVD) in maternity. She has contributed to better understanding on the pathophysiology, treatment options and awareness of peripartum cardiomyopathy (PPCM), a global disease particularly prevalent in African populations. 

She leads several inter-Africa research projects, which have had a major impact for creating knowledge about CVDs common in Africa, leading to changes in policy.   Her considerable experience in setting up simple, cost-effective registries and web-based data entry platforms have had a major impact on planning several innovative research projects and has facilitated the training of physicians from several African countries, including Mozambique, Nigeria, Cameroon, Uganda and Tanzania. Her research from bed-to-bench-to-bedside population studies have led to a much better understanding of CVDs in pregnant women and to improved care.

Professor Sliwa leads several high-profile special interest groups including a dedicated EORP Working Group on PPCM of the Heart Failure Association of European Society of Cardiology. Over her distinguished career she has served in many notable roles, including that of President of the South African Heart Association (2014-2016) and, currently, as President of the World Heart Federation (2019-2020).

I C Van Gelder (Groningen, NL)

Monday 2 September 10:20 - ESC Rene Laennec Lecture on Clinical Cardiology

Atrial fibrillation: not just an arrhythmia

I Van Gelder Photo.pngIsabelle C. Van Gelder obtained her MD in Groningen, the Netherlands  in 1986, her PhD in 1991, completed cardiology training in 1994, and electrophysiology training in 1996. Since 1995 she is working as cardiologist at the University Medical Center Groningen. Since 2006 she is Professor of Cardiology at the University of Groningen. She is Board member of EHRA and chair of the EHRA membership pillar, Secretary/ Treasurer of the ESC Stroke Council., sand a visiting professor of the University of Southern Denmark, Odense, Denmark. She was awarded with a Post Doc Netherlands Heart Foundation grant in 1994, an Interuniversity Cardiology Institute Netherlands post doc grant in 1995, and the Bert Talen medal in 2016 by the Netherlands Heart Rhythm Association. She received > €15 million research grants for atrial fibrillation research, published >300 peer reviewed papers, and is a promotor of > 15 PhD students. She is PI of >20 trials including the RACE trials and steering committee member of >15 international trials including EAST, AXAFA, ASSERT, RASTA-AF and STEEER AF. She is Task Force member of the ESC AF 2020 guidelines and Associate Editor of Europace. Her research focuses on understanding the susceptibility to atrial fibrillation and it adverse outcomes, and explores novel management strategies to prevent adverse outcomes in order to improve atrial fibrillation management.

Distinguished keynotes

G A Mensah (Bethesda, USA)  

Saturday 31 August 13:05 - Memorial lecture Bongani Mayosi

The 2019 Bongani Mayosi memorial lecture: cardiovascular health research, training, and capacity building in low-income and middle-income countries

George Mensah Photo.jpg

Professor Mensah is Director, Center for Translation Research and Implementation Science at the National Heart, Lung, and Blood Institute, a part of the US National Institutes of Health. He leads an effort to advance translational research and implementation science to address gaps in prevention, treatment, and control of heart, lung, blood, and sleep disorders.  His goal is to maximize the population health impact of advances made in basic, clinical, and population science research.  Prof Mensah is an honors graduate of Harvard University.  He obtained his medical degree from Washington University and trained in Internal Medicine and Cardiology at Cornell. His professional experience includes more than 25 years of public health service, direct patient care, teaching, and research at Cornell, Vanderbilt, and Medical College of Georgia. He is a Visiting full professor at the University of Cape Town. He has been admitted to fellowships at AHA, ACC, and ESC. He is an Honorary Fellow of the College of Physicians of South Africa.

H Ross (Toronto, CA)

Monday 2 September 18:00 Awards Ceremony - ESC Awards Inspirational Career Lecture

Heather Ross photo.jpg

Heather Ross, MD, MHSc, FRCP (C), FACC, FCCS is the Head, Division of Cardiology at the Peter Munk Cardiac Centre at UHN and Professor of Medicine at the University of Toronto. She is the Site Lead for the Ted Rogers Centre for Heart Research, and currently holds the Loretta A. Rogers Chair in Heart Function and the Pfizer Chair in Cardiovascular Research. She received her MD from the University of British Columbia, her Cardiology training at Dalhousie University, and a postdoctoral fellowship in Cardiac Transplantation at Stanford University, California. She earned her MHSc in Bioethics from the University of Toronto.

Dr. Ross has had numerous leadership roles including President of the Canadian Society of Transplantation in 2005, Executive of the International Society for Heart & Lung Transplantation (ISHLT 2002 – 2005) and ISHLT Secretary Treasurer 2007-2010.   She has served 11 years over two terms on the Canadian Cardiovascular Society Council, and is a past president of the CCS. She spent 6 years on the Board of the Canadian Cardiovascular Society Academy. She served 4 years on the Executive of the Heart Failure Society of America. She is an Associate Editor for the Journal of Heart and Lung Transplantation. She is the past Ted Rogers and Family Chair in Heart Function 2010-2017. She has published over 300 peer reviewed articles and won numerous teaching awards including the University of Toronto Teacher of the Year (2017), and the UHN Department of Medicine Michael Hutcheon Mentor Award (2017). In 2015, she was named by Canadian Geographic as one of the top 100 modern day explorers.

E Olson (Dallas, US) 

Eric Olson Photo.jpgSunday 1 September 10:10 - Inspirational Lecture in Translational Science

Eric Olson is Robert A. Welch Distinguished Professor and Chair of Molecular Biology at UT Southwestern Medical Center where he is currently Professor and Chair.  He and his trainees discovered many of the key genes and mechanisms that control heart and muscle development and disease.  His most recent work has provided a new strategy for correction of Duchenne muscular dystrophy using CRISPR gene editing. Dr. Olson is a member of the U.S. National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences.  He has co-founded multiple biotechnology companies to design new therapies for heart muscle disease.

French Cardiology Pioneers

Monday 2 September 17:00 - 17:45 ESC TV Stage, ESC Plaza
Organised by Societé Française de Cardiologie

Interact with four French Legends of Cardiology. Ask and learn about their specialised topic, their amazing career or any other question you may have!
Come and join them for informal discussions arising from a questions and answers format based on your remarks.

More in the next few days.

 

Meet the ESC Gold medalists

The European Society of Cardiology is pleased to honour a certain number of individuals in recognition of their outstanding achievements.

The 2019 ESC Gold Medals will be given at ESC Congress 2019, in Paris, during the Inaugural Session on Saturday 31 August at 17:00

Don't miss the "Meet the Gold Medalist" sessions on ESC TV Stage - A unique opportunity for an informal exchange and an inspiration to future generations.

See more